Alnylam Pharmaceuticals
ALNY
#640
Rank
$31.32 B
Marketcap
$242.83
Share price
-5.85%
Change (1 day)
42.85%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company